Latest Conference Articles

Managing Atopic Dermatitis in Special Populations: Expert Insights for Primary Care

Managing Atopic Dermatitis in Special Populations: Expert Insights for Primary Care

March 18th 2025

AAD

In an interview at AAD 2025, Katrina Abuabara, MD, stressed the importance of collaboration between primary care physicians and dermatologists.

Antihistamines Are a Poor Option to Treat Eczema in Older Adults: Clinical Pearl

Antihistamines Are a Poor Option to Treat Eczema in Older Adults: Clinical Pearl

March 18th 2025

AAD

Antihistamines for itch caused by disorders like atopic dermatitis pose more problems, like sedation and fall risk, than they provide relief, according to Daniel Butler, MD.

Emergence of Trichophyton Indotineae: A Call for Culture-Driven Antifungal Therapy

Emergence of Trichophyton Indotineae: A Call for Culture-Driven Antifungal Therapy

March 17th 2025

AAD

Elizabeth Swanson, MD, shares how the rise of T.indotineae, a terbinafine-resistant fungal species, has shifted her treatment approach.

Epinephrine Nasal Spray Shows Rapid Symptom Relief in Children: Daily Dose

Epinephrine Nasal Spray Shows Rapid Symptom Relief in Children: Daily Dose

March 17th 2025

AAAAI

Your daily dose of the clinical news you may have missed.

Daniel Butler, MD, a Leader in Geriatric Dermatology, Says Focus on the Overlap in the Etiology of Itch in Older Adults

Daniel Butler, MD, a Leader in Geriatric Dermatology, Says Focus on the Overlap in the Etiology of Itch in Older Adults

March 17th 2025

AAD

AAD 2025: Tracing the multiple pathways that contribute to chronic itch vs looking for a singular cause helps optimize choice of therapy, Butler says.

Rethinking Shingles in Children: Expert Insights for Primary Care

Rethinking Shingles in Children: Expert Insights for Primary Care

March 15th 2025

AAD

Shingles is increasingly being observed in healthy, immunocompetent children. Elizabeth Swanson, MD, discusses how to recognize and respond.

Measles Resurgence and Vaccine Efficacy: A Conversation with Elizabeth Swanson, MD

Measles Resurgence and Vaccine Efficacy: A Conversation with Elizabeth Swanson, MD

March 14th 2025

AAD

Dr Swanson discusses the resurgence of measles and emphasizes the safety and efficacy of the measles vaccine.

Upadacitinib Demonstrates Superior Regional, Overall Efficacy vs Dupilumab in Atopic Dermatitis: Level Up Phase 3b/4 Trial Findings

Upadacitinib Demonstrates Superior Regional, Overall Efficacy vs Dupilumab in Atopic Dermatitis: Level Up Phase 3b/4 Trial Findings

March 14th 2025

AAD

Dupilumab-treated participants with recalcitrant head and neck symptoms who were switched to upadacitinib rapidly reached EASI 75 and steadily improved, among other findings.

Dupilumab Cuts Food Allergy IgE Levels in Small Study: Daily Dose

Dupilumab Cuts Food Allergy IgE Levels in Small Study: Daily Dose

March 14th 2025

AAAAI

Your daily dose of the clinical news you may have missed.

Hand, Foot, and Mouth Disease Update: A Conversation with Elizabeth Swanson, MD

Hand, Foot, and Mouth Disease Update: A Conversation with Elizabeth Swanson, MD

March 13th 2025

AAD

Elizabeth Swanson, MD, discusses the changing face of HFMD, focusing on the increasingly prevalent coxsackievirus A6 strain and its unique characteristics